3,492 Shares in Danaher Co. (NYSE:DHR) Acquired by DSG Capital Advisors LLC

DSG Capital Advisors LLC bought a new position in shares of Danaher Co. (NYSE:DHR) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 3,492 shares of the conglomerate’s stock, valued at approximately $802,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Gilbert & Cook Inc. grew its stake in Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after buying an additional 42 shares during the last quarter. Spinnaker Trust grew its position in shares of Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after purchasing an additional 50 shares during the last quarter. Fortis Capital Advisors LLC increased its stake in shares of Danaher by 1.3% in the fourth quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock worth $914,000 after purchasing an additional 50 shares during the period. Fayez Sarofim & Co boosted its stake in Danaher by 0.6% during the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate’s stock valued at $1,902,000 after purchasing an additional 50 shares during the period. Finally, Coastal Bridge Advisors LLC grew its holdings in Danaher by 4.8% in the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate’s stock valued at $252,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 2.4%

Shares of NYSE DHR opened at $189.02 on Wednesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The firm has a 50 day moving average price of $194.08 and a 200 day moving average price of $214.67. The stock has a market cap of $135.28 billion, a P/E ratio of 35.80, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher’s payout ratio is currently 24.85%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on DHR. The Goldman Sachs Group cut their price target on Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a report on Wednesday, April 23rd. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday. Robert W. Baird cut their price target on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Barclays increased their price target on Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 22nd. Finally, Guggenheim reissued a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $263.24.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.